OrganoClick

Translation from CEO Mårten Hellbergs comments to the Interim Report.

Q3, 1 July - 30 September 2023

The Group compared with 2022

» Net revenue amounted to SEK 33.45 (22.26) million

» The gross margin amounted to 23.8 (11.9) %

» EBIT amounted to SEK -2.81 (-7.91) million

» Cash-flow from operating activities amounted to SEK 1.05 (3.54) million

1 January – 30 September 2023

The Group compared with 2022

» Net revenue amounted to SEK 117.96 (93.42) million

» The gross margin amounted to 25.6 (18.9) %

» EBIT amounted to SEK -3.10 (-18.83) million

» Cash-flow from operating activities amounted to SEK -6.13 (-21.33) million

The complete version of the Interim Report is attached in this press release and is available on the companys´ homepage. The informationen in this Interim Report is according to the rules of Nasdaq First North Growth Market.